Human Pathology
Volume 40, Issue 7 , Pages 934-941 , July 2009

Inactivation of O6-methylguanine-DNA methyltransferase in soft tissue sarcomas: association with K-ras mutations

  • Jeung Il Kim, MD

      Affiliations

    • Department of Orthopedics, School of Medicine, Pusan National University, Busan 602-739, Republic of Korea
    • ,
  • Jeung Tak Suh, MD

      Affiliations

    • Department of Orthopedics, School of Medicine, Pusan National University, Busan 602-739, Republic of Korea
    • ,
  • Kyung Un Choi, MD

      Affiliations

    • Department of Pathology, School of Medicine, Pusan National University, Busan 602-739, Republic of Korea
    • Corresponding Author InformationCorresponding author.
    • ,
  • Hyun Jeong Kang, MD

      Affiliations

    • Department of Pathology, School of Medicine, Pusan National University, Busan 602-739, Republic of Korea
    • ,
  • Dong Hoon Shin, MD

      Affiliations

    • Department of Pathology, School of Medicine, Pusan National University, Busan 602-739, Republic of Korea
    • ,
  • In Sook Lee, MD

      Affiliations

    • Department of Radiology, School of Medicine, Pusan National University, Busan 602-739, Republic of Korea
    • ,
  • Tae Yong Moon, MD

      Affiliations

    • Department of Radiology, School of Medicine, Pusan National University, Busan 602-739, Republic of Korea
    • ,
  • Won Taek Kim, MD

      Affiliations

    • Department of Therapeutic Radiology and Oncology, School of Medicine, Pusan National University, Busan 602-739, Republic of Korea

Received 1 October 2008 ,Revised 5 January 2009 ,Accepted 9 January 2009.

References 

  1. Weiss SW, Goldblum JR. 5th ed.. Enzinger and Weiss's soft tissue tumors. vol 1. St. Louis: Mosby; 2008;
  2. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res. 2001;61:3225–3229
  3. Kawaguchi K, Oda Y, Saito T, et al. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis. J Pathol. 2003;201:487–495
  4. Seidel C, Bartel F, Rastetter M, et al. Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma. Int J Cancer. 2005;114:442–447
  5. Brinck U, Schlott T, Storber S, et al. Alterations of the retinoblastoma and p16 pathway correlate with promoter methylation in malignant fibrous histiocytomas. Anticancer Res. 2006;26:3461–3465
  6. Kawaguchi K, Oda Y, Saito T, et al. DNA hypermethylation status of multiple genes in soft tissue sarcomas. Mod Pathol. 2006;19:106–114
  7. Yeager ND, Dolan ME, Gastier JM, et al. O6-methylguanine-DNA methyltransferase activity and promoter methylation status in pediatric rhabdomyosarcoma. J Pediatr Hematol Oncol. 2003;25:941–947
  8. Bae SI, Lee HS, Kim SH, Kim WH. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers. Br J Cancer. 2002;86:1888–1892
  9. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res. 1999;59:793–797
  10. Esteller M, Garcia-Foncillas J, Andion E, et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med. 2000;343:1350–1354
  11. Esteller M, Herman JG. Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer. Oncogene. 2004;23:1–8
  12. Grasbon-Frodl EM, Kreth FW, Ruiter M, et al. Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas. Int J Cancer. 2007;121:2458–2464
  13. Nagasaka T, Goel A, Notohara K, et al. Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis. Int J Cancer. 2008;122:2429–2436
  14. Al-Kuraya K, Narayanappa R, Siraj AK, et al. High frequency and strong prognostic relevance of O6-methylguanine DNA methyltransferase silencing in diffuse large B-cell lymphomas from the middle east. Hum Pathol. 2006;37:742–748
  15. Furonaka O, Takeshima Y, Awaya H, Kushitani K, Kohno N, Inai K. Aberrant methylation and loss of expression of O6-methylguanine-DNA methyltransferase in pulmonary squamous cell carcinoma and adenocarcinoma. Pathol Int. 2005;55:303–309
  16. Hengstler JG, Tanner B, Moller L, Meinert R, Kaina B. Activity of O(6)-methylguanine-DNA methyltransferase in relation to p53 status and therapeutic response in ovarian cancer. Int J Cancer. 1999;84:388–395
  17. Kang GH, Lee S, Lee HJ, Hwang KS. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. J Pathol. 2004;202:233–240
  18. Brell M, Tortosa A, Verger E, et al. Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas. Clin Cancer Res. 2005;11:5167–5174
  19. Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352:997–1003
  20. Hill MA, Gong C, Casey TJ, et al. Detection of K-ras mutations in resected primary leiomyosarcoma. Cancer Epidemiol Biomarkers Prev. 1997;6:1095–1100
  21. Stratton MR, Fisher C, Gusterson BA, Cooper CS. Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. Cancer Res. 1989;49:6324–6327
  22. Yoo J, Robinson RA. H-ras and K-ras mutations in soft tissue sarcoma: comparative studies of sarcomas from Korean and American patients. Cancer. 1999;86:58–63
  23. Yoo J, Robinson RA, Lee JY. H-ras and K-ras gene mutations in primary human soft tissue sarcoma: concomitant mutations of the ras genes. Mod Pathol. 1999;12:775–780
  24. Esteller M, Risques RA, Toyota M, et al. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res. 2001;61:4689–4692
  25. Esteller M, Toyota M, Sanchez-Cespedes M, et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res. 2000;60:2368–2371
  26. Park TJ, Han SU, Cho YK, Paik WK, Kim YB, Lim IK. Methylation of O(6)-methylguanine-DNA methyltransferase gene is associated significantly with K-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma. Cancer. 2001;92:2760–2768
  27. Laiho P, Launonen V, Lahermo P, et al. Low-level microsatellite instability in most colorectal carcinomas. Cancer Res. 2002;62:1166–1170
  28. Pulling LC, Divine KK, Klinge DM, et al. Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: More common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression. Cancer Res. 2003;63:4842–4848
  29. Komine C, Watanabe T, Katayama Y, Yoshino A, Yokoyama T, Fukushima T. Promoter hypermethylation of the DNA repair gene O6-methylguanine-DNA methyltransferase is an independent predictor of shortened progression free survival in patients with low-grade diffuse astrocytomas. Brain Pathol. 2003;13:176–184
  30. Blanc JL, Wager M, Guilhot J, et al. Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas. J Neurooncol. 2004;68:275–283
  31. Oue N, Shigeishi H, Kuniyasu H, et al. Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma. Int J Cancer. 2001;93:805–809
  32. Gerson SL. MGMT: its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer. 2004;4:296–307
  33. Kawaguchi K, Oda Y, Takahira T, et al. Microsatellite instability and hMLH1 and hMSH2 expression analysis in soft tissue sarcomas. Oncol Rep. 2005;13:241–246
  34. Friedman HS, Pegg AE, Johnson SP, et al. Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase. Cancer Chemother Pharmacol. 1999;43:80–85
  35. Ryan CW, Dolan ME, Brockstein BB, et al. A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma. Cancer Chemother Pharmacol. 2006;58:634–639
  36. Patra SK. Ras regulation of DNA-methylation and cancer. Exp Cell Res. 2008;314:1193–1201

PII: S0046-8177(09)00012-4

doi: 10.1016/j.humpath.2009.01.005

Human Pathology
Volume 40, Issue 7 , Pages 934-941 , July 2009

Article Tools

* Image Usage & Resolution